Work

Protocol for hybrid mass spectrometry-AI mapping of proteasome-generated HLA class I epitopes

Year: 2025
Type: article
Abstract: Proteasomes play a central role in antiviral and antitumor cytotoxic immunity, generating most of the >10,000 unique proteome-derived peptides bound to ∼200,000 human leukocyte antigen (HLA) class I molecules on each human cell. Here, we present a protocol for hybrid mass spectrometry-AI mapping of proteasome-generated HLA class I epitopes. We describe steps for in vitro processing of antigens by proteasomes, HLA class I allele selection, and peptide pool preparation. We then detail procedures for determining HLA class I ligands and population immunity. For complete details on the use and execution of this protocol, please refer to Kudriaeva et al. 1 • Steps for obtaining cell lines stably expressing HTBH-tagged proteasomes • Instructions for in vitro processing of antigens by proteasomes • Guidance on applying artificial AI to predict potential HLA class I peptide binders • Procedures for identifying physiologically relevant pools of HLA class I epitopes Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics. Proteasomes play a central role in antiviral and antitumor cytotoxic immunity, generating most of the >10,000 unique proteome-derived peptides bound to ∼200,000 human leukocyte antigen (HLA) class I molecules on each human cell. Here, we present a protocol for hybrid mass spectrometry-AI mapping of proteasome-generated HLA class I epitopes. We describe steps for in vitro processing of antigens by proteasomes, HLA class I allele selection, and peptide pool preparation. We then detail procedures for determining HLA class I ligands and population immunity.
Language: English
Open Access status: gold
Estimated APC paid: $1,550
OpenAlex ID: W4415544390
FWCI: 0.261
Cites: 8
Cited by: 1
Related to: